CI
BSX icon

Capital International’s Boston Scientific BSX Stock Holding History

Capital International’s Portfolio BSX Stock Details BSX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$5.34M Sell
125,193
-28,447
-19% -$1.54M 0.17% 105
2026
Q1 		$9.64M Sell
153,640
-85,225
-36% -$6.82M 0.36% 77
2025
Q4 		$22.8M Buy
238,865
+35,274
+17% +$3.46M 0.8% 36
2025
Q3 		$19.9M Sell
203,591
-18,298
-8% -$1.89M 0.72% 42
2025
Q2 		$23.8M Buy
221,889
+251
+0.1% +$25.4K 0.91% 30
2025
Q1 		$22.4M Buy
221,638
+16,902
+8% +$1.7M 0.97% 30
2024
Q4 		$18.3M Buy
204,736
+98,646
+93% +$8.68M 0.75% 37
2024
Q3 		$8.89M Buy
106,090
+35,430
+50% +$2.79M 0.38% 76
2024
Q2 		$5.44M Buy
70,660
+6,954
+11% +$509K 0.25% 92
2024
Q1 		$4.36M Buy
+63,706
New +$4.1M 0.21% 105
2021
Q1 		– Sell
-57,861
Closed -$2.08M – 157
2020
Q4 		$2.08M Sell
57,861
-342,830
-86% -$12.4M 0.12% 125
2020
Q3 		$15.3M Buy
400,691
+4,674
+1% +$180K 1.04% 26
2020
Q2 		$13.9M Sell
396,017
-5,329
-1% -$192K 1.3% 22
2020
Q1 		$13.1M Sell
401,346
-14,848
-4% -$580K 1.47% 17
2019
Q4 		$18.8M Buy
416,194
+131,058
+46% +$5.48M 1.98% 10
2019
Q3 		$11.6M Buy
285,136
+143,506
+101% +$6.08M 1.75% 13
2019
Q2 		$6.09M Buy
141,630
+716
+0.5% +$27.5K 1.45% 16
2019
Q1 		$5.41M Hold
140,914
– – 1.3% 19
2018
Q4 		$4.98M Buy
140,914
+6,026
+4% +$219K 1.35% 18
2018
Q3 		$5.19M Buy
134,888
+6,976
+5% +$244K 1.62% 12
2018
Q2 		$4.18M Hold
127,912
– – 0.73% 47
2018
Q1 		$3.5M Buy
127,912
+10,832
+9% +$294K 0.63% 55
2017
Q4 		$2.9M Buy
+117,080
New +$3.23M 0.55% 63

Other funds holding BSX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Capital International's BSX Position: Q2 2026 in Review

Capital International reduced its Boston Scientific (BSX) stake by 19% in Q2 2026, selling an estimated $1.54M and leaving 125,193 shares worth $5.34M. The position accounts for 0.17% of the portfolio, ranked #105.

Capital International first reported a position in BSX in Q4 2017 and has held it in 23 quarters since. The position peaked at $23.8M in Q2 2025. 1,477 funds tracked by Wall St. Rank hold BSX as of Q2 2026.

  • Capital International held 125,193 shares of Boston Scientific worth $5.34M as of Q2 2026.
  • Capital International sold 28,447 Boston Scientific shares in Q2 2026, an estimated $1.54M.
  • Boston Scientific made up 0.17% of Capital International's portfolio in Q2 2026, its #105 holding.
  • Capital International first reported a position in Boston Scientific in Q4 2017 and has held it in 23 quarters since.
  • Capital International's Boston Scientific position peaked at $23.8M in Q2 2025.
  • 1,477 funds tracked by Wall St. Rank held Boston Scientific as of Q2 2026.

Based on Capital International's 13F filing for Q2 2026, filed 12 Aug 2026.